+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Urine Monitoring Systems Market - Global Forecast Report 2024-2032

  • PDF Icon

    Report

  • 160 Pages
  • September 2023
  • Region: Global
  • Expert Market Research
  • ID: 5895154
The global urine monitoring systems market size was valued USD 571.6 million in 2023, driven by diabetes management, kidney diseases, rising aging population has led to market growth across the globe. The market size is anticipated to grow at a CAGR of 9.2% during the forecast period of 2024-2032 to achieve a value of USD 1262.0 million by 2032.

Urine Monitoring Systems: Introduction

Urine monitoring systems are medical devices designed to analyze and measure various parameters of a patient's urine. These systems play a crucial role in assessing kidney function, detecting potential medical conditions, and monitoring overall health. By providing insights into a patient's urinary parameters, healthcare professionals can diagnose diseases, track treatment progress, and make informed decisions about patient care. Urine monitoring systems consist of both hardware components and software interfaces that work together to collect, analyze, and present urine-related data. These systems are widely used in hospitals, clinics, laboratories, and even home healthcare settings to assess a range of health conditions and ensure timely intervention when needed.

Urine monitoring systems are an integral part of modern healthcare, enabling the early detection of health issues and continuous monitoring of patients' well-being. They provide valuable information to healthcare providers, helping them make informed decisions and improving patient outcomes. For the most up-to-date and comprehensive information, it's recommended to consult medical literature, healthcare associations, and industry reports.

Key Trends in Global Urine Monitoring Systems Market

  • Home Monitoring and Wearable Devices: There is a growing interest in developing urine monitoring systems for home use. Wearable devices and portable urine analysis tools empower patients to monitor their health on a regular basis, facilitating early detection and management of chronic conditions.
  • Personalized Medicine and Data Analytics: Urine monitoring systems are contributing to the broader trend of personalized medicine. These systems collect a wealth of data that can be analyzed to provide insights into an individual's health status and trends. Advanced data analytics can help predict health outcomes and guide personalized treatment plans.
  • Non-Invasive and User-Friendly Designs: Manufacturers are focusing on designing user-friendly, non-invasive urine monitoring systems. This includes devices with simpler sample collection methods, easy-to-use interfaces, and minimized discomfort for patients.
  • Remote Patient Monitoring: Remote patient monitoring has gained traction, especially during the COVID-19 pandemic. Urine monitoring systems that support remote monitoring enable healthcare providers to track patient data, make informed decisions, and offer virtual consultations when necessary.

Global Urine Monitoring Systems Market Segmentation

The market can be categorised into product type, usage, end user and region.

Market Breakup by Product type

  • Manual
  • Automatic

Market Breakup by Usage

  • Disposable
  • Reusable

Market Breakup by End User

  • Hospitals
  • Specialty Clinics
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Urine Monitoring Systems Market Overview

The urine monitoring systems market encompasses medical devices and technology designed to analyze and measure various parameters within a patient's urine. These systems play a critical role in assessing kidney function, detecting medical conditions, and monitoring overall health. Urine monitoring systems are used in healthcare facilities, laboratories, clinics, and even home settings to provide valuable insights into a patient's urinary health. The urine monitoring systems market has experienced growth driven by factors such as increasing prevalence of chronic diseases (e.g., diabetes, kidney diseases), aging populations, and a rising emphasis on preventive healthcare. The demand for early disease detection and personalized treatment is fueling the adoption of urine monitoring systems. The urine monitoring systems market has experienced growth driven by factors such as increasing prevalence of chronic diseases (e.g., diabetes, kidney diseases), aging populations, and a rising emphasis on preventive healthcare. The demand for early disease detection and personalized treatment is fueling the adoption of urine monitoring systems.

Key Players in the Global Urine Monitoring Systems Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

The major companies in urine monitoring systems market are as follows:

  • Future Path Medical Holding Company LLC
  • Cardinal Health
  • Potrero Medical
  • Navamedic ASA
  • F. Hoffmann-La Roche Ltd.
  • RenalSense Ltd.
  • Roche Holding AG
  • Medispec Ltd
The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Urine Monitoring Systems Market Overview
3.1 Global Urine Monitoring Systems Market Historical Value (2017-2023)
3.2 Global Urine Monitoring Systems Market Forecast Value (2024-2032)
4 Global Urine Monitoring Systems Market Landscape
4.1 Global Urine Monitoring Systems Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Urine Monitoring Systems Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Usage
5 Global Urine Monitoring Systems Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Urine Monitoring Systems Market Segmentation
6.1 Global Urine Monitoring Systems Market by Product Type
6.1.1 Market Overview
6.1.2 Manual
6.1.3 Automatic
6.2 Global Urine Monitoring Systems Market by Usage
6.2.1 Market Overview
6.2.2 Disposable
6.2.3 Reusable
6.3 Global Urine Monitoring Systems Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Specialty Clinics
6.3.4 Others
6.4 Global Urine Monitoring Systems Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Urine Monitoring Systems Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Urine Monitoring Systems Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Urine Monitoring Systems Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Urine Monitoring Systems Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Urine Monitoring Systems Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Future Path Medical Holding Company LLC
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Cardinal Health
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Potrero Medical
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Navamedic ASA
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 F. Hoffmann-La Roche Ltd.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 RenalSense Ltd.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Roche Holding AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Medispec Ltd
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
18 Global Urine Monitoring Systems Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Future Path Medical Holding Company LLC
  • Cardinal Health
  • Potrero Medical
  • Navamedic ASA
  • F. Hoffmann-La Roche Ltd.
  • RenalSense Ltd.
  • Roche Holding AG
  • Medispec Ltd

Methodology

Loading
LOADING...